Sirtris, a GSK company, is developing small molecule drugs that target the sirtuins.
Business Model:
Revenue: $15.6M
Employees: 11-50
Sirtris was acquired by
GlaxoSmithKline.
The acquisition happend on 2008-04-22.
Details of the transaction were not public
Address: 200 Technology Sq
City: Cambridge
State: MA
Zip: 02139
Country: US
Sirtris, a GSK company, is developing small molecule drugs that target the sirtuins.
Contact Phone:
+16172526920
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|